ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0193

Social Vulnerability Associations with Mortality in a Lupus Cohort

Sean Carter1, Dulaney Wilson1, Samantha Minkin2, David Dillon3, Baxter Murray1, John Pearce1 and Jim Oates1, 1Medical University of South Carolina, Charleston, SC, 2Vanderbilt University Medical Center, Nashville, TN, 3Rheumatology Associates of South Florida, Delray Beach, FL

Meeting: ACR Convergence 2023

Keywords: Mortality, socioeconomic factors, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0176–0195) Healthcare Disparities in Rheumatology Poster I: Lupus

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: The goal of this study is to identify characteristics of socially vulnerable environments associated with increased mortality in a South Carolina systemic lupus erythematosus (SLE) cohort.   

Methods: Address, demographic, medication use, and SLE International Collaborating Clinics (SLICC) disease damage data were gathered prospectively from patients and their medical record enrolled in the Medical University of South Carolina’s (MUSC’s) lupus registry that met SLE criteria. Death certificate data for patients in the cohort were obtained from the state Department of Health. Standardized mortality ratios (SMR) were calculated using expected mortality rates from the CDC WONDER database, and characteristics between deceased and living patients were compared. The cohort was linked with geospatial analysis to publicly available census tract contextual data, which was CDC’s Social Vulnerability Index (SVI). Then, we applied spatial regression models to assess associations between neighborhood characteristics and SLE outcomes after controlling for age, sex, education, disease characteristics and also examined effect modification of each characteristic by presence of disease damage

Results: 712 subjects were included in the final analysis, and 102 died before the study data cutoff. The total SMR adjusted for age, race, and gender was 12.29 (95% CI 9.97-14.61). Of the deceased, there was a statistically significant increased mortality in association with self-identified Black race (p=0.02), with high vulnerability census tracts, and total, renal-related, and steroid-related SLICC damage index (SDI) of 1 or more (p< 0.01) and a reduced mortality associated with hydroxychloroquine use. Black patients had higher SDI compared to White patients. Patients with SDI of 1 or more were at increased risk of mortality if they lived in a minority neighborhood, had no high school diploma, had low socioeconomic status, or spoke English less than well  

Conclusion: Mortality and SDI were significantly greater in Black patients, which, as race is a social construct, prompted evaluation of socially vulnerable environments using SVI which found an increased risk of mortality in socially vulnerable census tracts and this effect was greater in patients with disease damage. The cause of this association is not known. However, the significant association between socially vulnerable environments and mortality suggests the need to study environmental factors that influence the high rate of mortality among lupus patients in SC and should prompt awareness. The significant association between hydroxychloroquine and lower mortality is consistent with other prospective cohort studies and reinforces the current guidelines regarding its use in SLE.

Supporting image 1

Table 1 – SLE Cohort Demographics & Clinical Characteristics Associated with mortality

Supporting image 2

Table 2 – Social Vulnerability Variable Effect Modification on Mortality based on presence or absence of SDI


Disclosures: S. Carter: None; D. Wilson: None; S. Minkin: None; D. Dillon: None; B. Murray: None; J. Pearce: None; J. Oates: None.

To cite this abstract in AMA style:

Carter S, Wilson D, Minkin S, Dillon D, Murray B, Pearce J, Oates J. Social Vulnerability Associations with Mortality in a Lupus Cohort [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/social-vulnerability-associations-with-mortality-in-a-lupus-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/social-vulnerability-associations-with-mortality-in-a-lupus-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology